Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 657.80

+1.7%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biotechwantabe who wrote (3255)	3/23/2021 11:12:54 AM
From: A.J. Mullen	Read Replies (1) of 3557

Phase III shows cocktail reduces hospitalization or death by 70% in high-risk non-hospitalized patients. That's good news, particularly with age over 50 as a sufficient condition to determine high-risk. Does anyone have an idea of the cost of the goods? Covid will be with us for some time yet. It might become very profitable if insurance or Medicare would routinely pick up the tab for anyone over 50, with a high BMI, etc.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next